Two of the FTSE 100's largest companies are among the global drugs giants seeking to clarify how they would be affected by a ...

Thanks to Trump's exemptions, the majority of pharma groups will only be subject to the specific tariffs of the country in ...

Trump announced another round of wide-ranging tariffs, sparking questions about their implications for consumers and ...

The US leader has fumed because prescription drugs cost more in the US than in any other country. Read more at ...

European companies, a major source of U.S. medicines, are hopeful that their investments and trade deals with the U.S. will ...

The British government will offer to pay more for medicines that it buys for the National Health Service, the Financial Times ...

The timing could hardly have been worse. Britain’s pharmaceutical industry was already struggling with arguments over the ...

President Trump's recent tariff announcement targets the global pharmaceutical sector, imposing a 100% tariff on imported ...

The US president's latest tariff move will see the US impose 100% levies on imports of branded or patented pharmaceutical ...

Stocks climbed Friday as investors digested a new tariffs blitz by US President Donald Trump and data showing a key US ...

Trump argues tariffs will boost domestic production and strengthen supply chains. He has also linked the policy to lower drug ...

The site dates back to 1876 and has seen several owners since privatisation in 1989, with French firm Alstom taking over in ...